Trova

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety

4.7 (551) · € 16.99 · In Magazzino

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate  Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine  Scaffold: SAR of the Biphenyl Moiety
Microorganisms, Free Full-Text

Microorganisms, Free Full-Text

PDF) Dihydroorotate dehydrogenase inhibition reveals metabolic  vulnerability in chronic myeloid leukemia

PDF) Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia

Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in  chronic myeloid leukemia

Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia

Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a  benzophenone scaffold - ScienceDirect

Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold - ScienceDirect

Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates: Trends  in Cancer

Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates: Trends in Cancer

Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in  chronic myeloid leukemia

Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia

Molecules, Free Full-Text

Molecules, Free Full-Text

Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer  therapy: Current development and future perspectives - ScienceDirect

Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives - ScienceDirect

Biochemical characterization of Mycobacterium tuberculosis dihydroorotate  dehydrogenase and identification of a selective inhibitor - Alberti - 2023  - FEBS Letters - Wiley Online Library

Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitor - Alberti - 2023 - FEBS Letters - Wiley Online Library